DexCom, Inc.
DXCM
Rang in Aktien
#751
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Aktienkurs
$86.01
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$32.45B
Veränderung (1 Tag)
-0.04%
Veränderung (1 Jahr)
25.68%
Land
US
Handel DexCom, Inc. (DXCM)
Kategorie
Healthcare
Gewinn für DexCom, Inc. (DXCM)
Gewinn im Jun 2026 TTM: $1.28B
Laut den aktuellen Finanzberichten von DexCom, Inc. betragen die aktuellen Gewinne des Unternehmens $1.28B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $709.00M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2023, der $710.40M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von DexCom, Inc. von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $1.28B | 17.60% |
| 2025 | $1.09B | 53.51% |
| 2024 | $709.00M | -0.20% |
| 2023 | $710.40M | 81.78% |
| 2022 | $390.80M | 52.18% |
| 2021 | $256.80M | 14.13% |
| 2020 | $225.00M | 115.93% |
| 2019 | $104.20M | -182.37% |
| 2018 | $-126.50M | 160.29% |
| 2017 | $-48.60M | -25.12% |
| 2016 | $-64.90M | 12.87% |
| 2015 | $-57.50M | 157.85% |
| 2014 | $-22.30M | -25.17% |
| 2013 | $-29.80M | -46.59% |
| 2012 | $-55.80M | 24.70% |
| 2011 | $-44.75M | -18.89% |
| 2010 | $-55.17M | 3.08% |
| 2009 | $-53.52M | -3.01% |
| 2008 | $-55.18M | 20.28% |
| 2007 | $-45.88M | -1.55% |
| 2006 | $-46.60M | -99.85% |
| 2005 | $-30.89B | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.51B | 486.80% |
US
|
|
| $5.56B | 334.61% |
IE
|
|
| $5.15B | 302.19% |
US
|
|
| $3.86B | 201.64% |
US
|
|
| - | - |
DE
|
